Med Ad News asked Adrienne Morgan and Geetiksa Prasad, the account and copy leads for Ibrance at H4B Chelsea, about their agency’s work with Pfizer’s star breast cancer brand.
The good news … is that innovation is addressing diseases with high-unmet need such as oncology, autoimmune diseases, and central nervous system (CNS) disorders. But, there is a complicating factor in the economic story: the patient population benefiting from launch brands is becoming smaller.
First Year After Launch: New molecular entities launched in the U.S. during 2015 that generated 2016 sales of at least $200 million
A listing of the the new molecular entities launched in the United States during 2015 that generated 2016 sales of at least $200 million
Leading healthcare and pharma communications professionals from around the globe convened at the fourth annual Lions Health festival on June 17-18, 2017, in Cannes, France. Key trends and issues in healthcare communications were explored during “two days of life-changing creativity.” Following are perspectives on various topics from some of the industry experts who attended this year’s event …
While the nation’s media was focusing on the unsuccessful attempts by Republicans to pass a successor to Obamacare, a fascinating sideshow has developed in nearby White Oak, Maryland, home of the Food and Drug Administration.
Decades ago, healthcare professionals along with the rest of the population were swamped with promotional direct mail. But in recent years, new technology like email, SMS, mobile applications, and AR/VR have diversified the ways in which healthcare marketers can reach physicians.
Change is inevitable, and evolving and growing with it is the only way to move forward. That’s just a fact. Those in our industry who aren’t willing to embrace the constant changes we’re seeing in technology, trends, and now how we market health and wellness brands, are going to be left behind because journal ads, banner ads and TV commercials as exclusive mediums will likely not sufficiently reach a brand’s target audiences any longer.
ZS oncology experts Christina Corridon and Pavan Anne discuss their recent survey of physicians, payers, and pharmacy managers regarding attitudes toward biosimilars
Most health plans are covering at least one of the two biosimilar products currently on the market, according to new research by the strategic advisory company Avalere.
Four in five oncologists have tried Zarxio/Granix, according to a new survey by ZS Associates. Of those, 48 percent prescribe the reference biologic more than the biosimilar, 43 percent prescribe the biosimilar more, and 8 percent have equal prescriptions for the reference biologic and the biosimilar.
At its core, “Customer experience,” or CX, is shorthand for the relationship between a customer and a company, even if that company is removed from the point of sale. The CX relationship should stretch across all touchpoints both physical and virtual and all media in between. Today’s customers expect companies to know and understand them, creating a seamless experience across the entire customer-company relationship.
Just 27 percent of physicians say they find pharma websites to be a credible source of professional information, according to a recent survey by Manhattan Research.
The Fishawack Group of Companies – one of the largest independent medical communications organizations – acquired the Carling Group of Companies, based in San Diego, Calif.
Fingerpaint named a longtime creative duo as the new leaders of the agency’s creative team. Katie Beller and Andy Spitzer are based in the agency’s headquarters in Saratoga Springs, New York.
Keri Hettel was made senior VP, Analytics and Strategy, and Brandon Ashcraft was promoted to senior VP, Operations, at Razorfish Health.
UDG Healthcare acquired Cambridge BioMarketing, a U.S.-based healthcare communications business, for a total consideration of up to $35 million.
Discovery Worldwide appointed Rico Ricketson as head of client services.
Guy Mastrion, an entrepreneur and creative industry veteran with more than 30 years of experience in brand development, digital strategy, advertising, design, photography, and film for global brands, was appointed the ninth F. William Harder Chair of Business at Skidmore College.
Healthcare communications agency Calcium hired Damon Tutulic as senior VP, management director.
Dr. Craig Landau was appointed president and CEO of Purdue Pharma LP, the U.S. operations of Purdue Pharma headquartered in Stamford, Conn. He retains responsibility for Purdue Pharma (Canada).